SCHEMBL791253

SCHEMBL791253

C[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17164603 1.00 CYP1A2 (0.55)
SCHEMBL105210 1.00
SCHEMBL2599566 1.00
SCHEMBL105145 0.97 CYP1A2 (0.52)
Ammonia Solution, Strong SCHEMBL20582897 0.97 TDP1 (0.55)
SCHEMBL6737976 0.97 CYP1A2 (0.52)
SCHEMBL10884759 0.97 CYP1A2 (0.52)
Hydrochloric Acid SCHEMBL8052774 0.97 CYP1A2 (0.52)
SCHEMBL106819 0.97 CYP1A2 (0.52)
Ethane SCHEMBL5873454 0.97 CYP1A2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104610363-B Phosphorous amide ligand and its preparation method and application 中山大学 2018-04-10 CN claimed
CN-106831862-A Axial chirality monophosphorus ligand of one class chirality bridging and preparation method thereof 中山大学 2017-06-13 CN claimed
CN-102875601-B Phosphine-oxazoline ligand and ionic type metal title complex thereof and its enantiomorph or raceme preparation method and application SUN YAT-SEN UNIVERSITY (CN) 2016-03-09 CN claimed
CN-102532196-B Phosphine ligands and enantiomorph or raceme and preparation method thereof SUN YAT-SEN UNIVERSITY (CN) 2015-09-02 CN claimed
CN-104610363-A Phosphoramidite ligand as well as preparation method and application thereof UNIV SUN YAT SEN 2015-05-13 CN claimed
CN-102875601-A Preparation method and application for phosphine-oxazoline ligand, and ionic metal complex, enantiomer or racemate thereof UNIV SUN YAT SEN 2013-01-16 CN claimed
EP-1504002-B1 METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE BETA-AMINOKETONES AND OPTICALLY ACTIVE 1,3-AMINOALCOHOLS SANOFI AVENTIS DEUTSCHLAND (DE) 2012-12-19 EP claimed
CN-102532196-A Phosphine ligand and enantiomer or racemic body thereof and preparation methods thereof UNIV SUN YAT SEN 2012-07-04 CN claimed
CN-102516300-A Phosphine ligands, enantiomers or racemates thereof, and preparation methods of above UNIV SUN YAT SEN 2012-06-27 CN claimed
US-7161008-B2 Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them Sanofi - Aventis Deutschland GmbH (DE) 2007-01-09 US claimed
US-20040030145-A1 Optically active B-aminoketones, optically active 1,3-amino alcohols and processes for preparing them AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-02-12 US claimed
CN-119019400-A Prodrugs of GS-441524 and medical application thereof 中国药科大学 2024-11-26 CN disclosed
US-20230256109-A1 Trans-Cyclooctene Bioorthogonal Agents and Uses in Cancer and Immunotherapy TAMBO, INC. 2023-08-17 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11236122-B2 Triterpene amine derivatives DFH THERAPEUTICS (US) 2022-02-01 US disclosed
WO-2001034209-A1 LIGANDS FOR α7 NICOTINIC ACETYLCHOLINE RECEPTORS BASED ON METHYLLYCACONITINE RESEARCH TRIANGLE INSTITUTE (US) 2001-05-17 WO disclosed
US-5997840-A A BEA TOPOLOGY ZEOLITE AND A METAL-BINAP COMPLEX K.V. LEUVEN RESEARCH & DEVELOPMENT (BE) 1999-12-07 US disclosed
EP-0855935-A1 CHIRAL SOLID CATALYST, ITS PREPARATION AND ITS USE FOR THE PRODUCTION OF SUBSTANTIALLY ENANTIOMERICALLY PURE PRODUCTS K.U. Leuven Research & Development (BE) 1998-08-05 EP disclosed
WO-1997014500-A1 CHIRAL SOLID CATALYST, ITS PREPARATION AND ITS USE FOR THE PRODUCTION OF SUBSTANTIALLY ENANTIOMERICALLY PURE PRODUCTS K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 1997-04-24 WO disclosed
US-5321139-A Amination of phenylitaconic anhydride, catalytic reduction of formed amide; renin inhibitor HOECHST AKTIENGESELLSCHAFT (DE) 1994-06-14 US disclosed